ELIAS JOSEPH JABBOUR to Arsenicals
This is a "connection" page, showing publications ELIAS JOSEPH JABBOUR has written about Arsenicals.
Connection Strength
0.283
-
Value of measurable residual disease monitoring in patients with acute promyelocytic leukemia in the era of frontline 'chemotherapy-free' therapy. Leuk Lymphoma. 2022 03; 63(3):672-675.
Score: 0.189
-
New agents in myelodysplastic syndromes. Curr Hematol Rep. 2005 May; 4(3):191-9.
Score: 0.060
-
Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab. Blood. 2017 03 09; 129(10):1275-1283.
Score: 0.034